Disease/Infection News

RSS

Research supports cautious re-opening of schools

The gradual reopening of schools, starting with primary schools, is unlikely to lead to a second wave of infection, according to new mathematical modelling of the COVID-19 outbreak from University of Warwick researchers, but we should be prepared to reintroduce lockdown measures should there be a significant rise in the number of new cases.

4 Jun 2020

Judges try to balance legal rights and courtroom health

It's tough getting people to report for jury duty in normal times. It's even harder during a pandemic.

4 Jun 2020

WHO's new data reveals high levels of antibiotic resistance worldwide

WHO's first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.

4 Jun 2020

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Eli Lilly and Company today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19.

4 Jun 2020

COVID-19 pandemic may cause long-term effects and increase healthcare costs, says GlobalData

As many COVID-19 patients may experience long-term complications from the illness such as intensive care unit delirium, post-traumatic stress disorder, lung damage, heart damage and possible neurological issues, GlobalData expects the market for these treatments to increase due to the COVID-19 pandemic as recovered patients may need long-term care for these issues after being released from the intensive care unit and the hospital.

4 Jun 2020

GlobalData: Nearly 83.5% of orthopedic procedures estimated to be delayed in the U.S.

Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.

4 Jun 2020

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19.

4 Jun 2020

27 protein biomarkers predict COVID-19 severity in patients

Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.

4 Jun 2020

An approach for caring patients in COVID-19 units

Toronto and Spanish physicians describe in CMAJ (Canadian Medical Association Journal) an approach to create dedicated COVID-19 patient units, infection control protocols and care teams to help other hospitals safely care for patients.

4 Jun 2020

COVID‐19 epidemics could be seasonal, peaking during the cold season

Now, a new study shows the link between lower humidity and an increase in locally acquired positive cases of the coronavirus disease (COVID-19), which means that outbreaks may happen during the winter season.

4 Jun 2020

Distancing, masks and eye gear protects against spread of SARS-CoV-2 finds large study

In a comprehensive systemic analysis of different studies, researchers have found that physical distancing, use of face masks, and eye protection were the most effective ways to prevent the spread of SARS-CoV-2 infection from one person to another.

4 Jun 2020

Avoiding 'air hunger' and psychological trauma in COVID-19 ARDS survivors

A new paper published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome with mechanical ventilation.

4 Jun 2020

Two strategic roadmaps include recommendations to advance value-based care in the U.S.

The Duke-Margolis Center for Health Policy and West Health have issued two strategic roadmaps with recommendations for advancing value-based payment (VBP) reform in the U.S. healthcare system.

4 Jun 2020

GlobalData: India has relatively low COVID-19 average case fatality rate despite surge in cases

With a total of nearly 200,000 confirmed cases and over 5,500 deaths reported due to COVID-19 in the past three months, India stands in tenth position in terms of the number of confirmed cases.

4 Jun 2020

New mobile app can help the severity of COVID-19 cases

A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases.

4 Jun 2020

Health care providers urged to stop hydroxycholoroquine use for COVID-19

The sacred oath taken by physicians during graduation from medical school to "First do no harm," the first words of the Hippocratic Oath, provides a strong impetus for a commentary just published in The American Journal of Medicine.

4 Jun 2020

Study says vitamin-magnesium combo may reduce severity of COVID-19 in seniors

The COVID-19 pandemic that began in late December 2019 has spread to over 188 countries and territories, causing over 6.5 million cases and 385,000 deaths. With no effective therapeutic COVID-19 drug or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in sight, researchers are exploring different strategies to limit its spread and mortality.

4 Jun 2020

Age and diabetes the biggest risk factors for death in pregnant COVID-19 patients

A recent research letter published on the preprint server medRxiv in June 2020 evaluates the risk factors that may lead to higher mortality in pregnant women with COVID-19 in middle-income countries.

4 Jun 2020

Drug Teixobactin shows promise against drug-resistant superbugs

Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, “The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study,” was published in the latest issue of the journal Therapeutics and Prevention.

4 Jun 2020

How COVID-19 affects people with Down Syndrome

A new study published in June 2020 on the preprint online server medRxiv reports on the increased risk of COVID-19 in Down Syndrome (DS) and certain characteristic features that are found in this population segment.

3 Jun 2020

Disease/Infection News

Research supports cautious re-opening of schools

Judges try to balance legal rights and courtroom health

WHO's new data reveals high levels of antibiotic resistance worldwide

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

COVID-19 pandemic may cause long-term effects and increase healthcare costs, says GlobalData

GlobalData: Nearly 83.5% of orthopedic procedures estimated to be delayed in the U.S.

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

27 protein biomarkers predict COVID-19 severity in patients

An approach for caring patients in COVID-19 units

COVID‐19 epidemics could be seasonal, peaking during the cold season

Distancing, masks and eye gear protects against spread of SARS-CoV-2 finds large study

Avoiding 'air hunger' and psychological trauma in COVID-19 ARDS survivors

Two strategic roadmaps include recommendations to advance value-based care in the U.S.

GlobalData: India has relatively low COVID-19 average case fatality rate despite surge in cases

New mobile app can help the severity of COVID-19 cases

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Study says vitamin-magnesium combo may reduce severity of COVID-19 in seniors

Age and diabetes the biggest risk factors for death in pregnant COVID-19 patients

Drug Teixobactin shows promise against drug-resistant superbugs

How COVID-19 affects people with Down Syndrome

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News